Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 109,332 | 92,761 | 93,401 | 86,742 | 82,491 |
| Cost of Goods | 1,699 | 1,265 | 1,557 | 1,099 | 894 |
| Gross Profit | 107,633 | 91,496 | 91,844 | 85,643 | 81,597 |
| Operating Expenses | 99,571 | 106,249 | 135,071 | 97,663 | 103,194 |
| Operating Income | 8,761 | -14,488 | -42,670 | -11,921 | -20,703 |
| Interest Expense | 24,733 | 24,506 | 24,583 | 27,345 | 28,915 |
| Other Income | 3,470 | 3,980 | 4,091 | 3,447 | -24,968 |
| Pre-tax Income | -12,502 | -35,014 | -63,162 | -35,819 | -74,586 |
| Income Tax | 172 | 365 | -1,431 | 330 | 740 |
| Net Income Continuous | -12,674 | -35,379 | -61,731 | -36,149 | -75,326 |
| Net Income | $-12,674 | $-35,379 | $-61,731 | $-36,149 | $-75,326 |
| EPS Basic Total Ops | -0.06 | -0.17 | -0.31 | -0.19 | -0.40 |
| EPS Basic Continuous Ops | -0.06 | -0.17 | -0.31 | -0.19 | -0.40 |
| EPS Diluted Total Ops | -0.06 | -0.17 | -0.31 | -0.19 | -0.40 |
| EPS Diluted Continuous Ops | -0.06 | -0.17 | -0.31 | -0.19 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.17 | -0.28 | -0.19 | -0.24 |
| EBITDA(a) | $5,588 | $-17,363 | $-45,696 | $-14,098 | $-23,128 |